IZX is a platform for integrating LLMs into business applications, enabling natural language understanding and automation. Our product streamlines the creation, inference, and scaling of enterprise foundational models (that can also be hosted on-premise or in private cloud) that interact with external LLMs, APIs, and data sources. Our team includes the top 1% of AI/ML engineers in Europe. Join our team!

Quine develops workflow and automation solutions for the film and broadcast community. We work with different partners such as ARRI, LADIO, Microsoft, NRK, Telia to find the best solutions and distribute them to our customers worldwide. Quine was founded December 2016. Simula Research Laboratory joined in when activity started in January 2017. Competence, industry- and tech knowledge in addition to a close connection to our customer base and main markets, are currently our main strengths.

The story of Lingu started in the non-profit organization KIA which works with integration and Norwegian language teaching. The founders Edward Milsom and Odd Bjerga worked in this organization and came into contact with skilled and resourceful people from many different countries. The idea of ​​Lingu arose in this context of migration and communication, and human talents. The website lingu.no was launched on 16 December 2008, and our first language course started on KIA's premises in January 2009, with course providers from KIA's network. Since its inception, the company has grown and become a leading player in the language market in Norway. Lingu is today an ed-tech company and course provider with course centers in several cities. The company's management consists of an innovative and curious crew with a long career in adult education and a heart for language, technology, and pedagogy. As a company, we want to offer engaging and digital solutions for our users, as well as facilitate personal development for the people we work with. By linking talent, technology, and pedagogy, we create products and services that enable communication and interaction across language barriers. Our products and services will expand the horizons for people, and create both new career opportunities and greater tolerance in a diverse world. Our vision is to help millions of learners master new languages ​​through local classrooms and online learning. Our mission is to merge technology and pedagogy, and give the teacher digital superpowers: Create language heroes who expand human horizons

Flow Insights is a data, insights, and analytics partner for physical retail. We work with some of the most recognized brands and retailers in the world. Clients use us to make faster and more accurate assortment and space decisions to improve shoppability, reduce waste, simplify operations, and increase profitability.

We want to make our cities green. Literally. Urban green infrastructure is one of the most important climate adaptation instruments for cities. They help manage water, temperature, air quality and improve life quality. The design process, the sourcing of plants and the maintenance systems for these spaces are however challenging today: they are not fit to properly respond to the ever more demanding regulations and the increased complexity of projects. We are solving this with a platform for all urban green spaces stakeholders. Put simply we want to create the OTOVO of urban green spaces. This means we are orchestrating stakeholders to make sure the right plants are used in the right place to create cities we thrive in.

Material Mapper’s vision is to create a market of scale for secondary building materials by mapping them in Europe and leading the transition towards a closed-loop circular construction and demolition industry. The European construction industry is urgently lacking clear, centralized access to information about secondary building materials available in their area, due to the fragmentation and inconsistency with which these public data are captured and stored. This makes building planning with quality secondary building materials time and cost-intensive for stakeholders, in turn making it difficult to comply with the EU’s Waste Directive of 70% recycled/re-used building materials. Our young, multi-award-winning company is planning to launch a project over 24 months to build a breakthrough innovation for the whole of Europe using artificial intelligence and machine learning that will extract, read, evaluate, and forecast quantities of secondary building materials for the user, making future planning for property developers seamless through our platform. We are confident that our product is unique and that we have no direct competition. By combining our deep technology, partnership development, and B2B sales expertise, we are already working closely with major industry actors to harness insights and their existing networks for our customer base.

Cycl works to solve plastic pollution by using available technology in a sensible way. Our vision is to give value to every single plastic and minimize plastic waste by 100% in all countries we operate in. Cycl is a mobile app that can tell our users about nearby recycling stations, when their bottle is recycled we make sure that they get rewarded for their work.

PUBLICAE offers Tokenization of Political Attention by Empowering Citizens with Social & Economic Equity. Emancipation and enlightenment of the electorate increases voter turn-out and strengthens ethical-normative democratic principles. PUBLICAE ́s blockchain-based Ad-tech reward system is a public discourse, a dialectic exchange of conceptualised values which enables outreach efforts and organisational advertising strategies with rewarded audience targeting. Users can earn $STATE for their awareness as a token of appreciation by watching video ads from verified publishers like political parties, NGOs, educational institutions and faith based communities.

Rada Labs are bringing app ideas to life. With a big focus on creativity and innovation the company develop never seen before applications for smartphones, tablets, smart watches and computers. Rada Labs consists of creative people who love to develop high quality products and services. With innovation in focus, we develop our own brands within apps as well as develop applications for our customers. We build apps for smartphones, smartwatches, tablets and computers. By using tailored innovation processes and the latest technology in cloud services, machine learning and artificial intelligence, we can create smart applications that reach all target groups!

STYRETAVLA Boligsameiets/borettslagets nye digitale oppslagstavle! Styretavla er en naturlig digitalisering og modernisering av den tradisjonelle korktavla. Den eneste informasjonsplattformen alle beboere eksponeres for jevnlig, uavhengig av alder og kompetanse. Løsningen er basert på erfaringer og utfordringene som kommer med styrevervet og den generelle problematikken rundt informasjonsflyt i boligsameier og borettslag. Styretavla har base i enkelhet og har flere fordeler for styret, beboere og tredjeparter.

WiSub Acquired by Transmark Subsea The acquisition will strengthen their ability to provide solutions for the growing market for underwater autonomy and wireless drone docking. WiSub is an ocean technology company based in Bergen, Norway. They supply patented, innovative, and flexible wet-mate pinless underwater connection systems to international markets. Transmark Subsea manufactures a broad range of qualified cable systems for the distribution of electrical signals, power, and fiber optics to the offshore subsea industry. Transmark Subsea design, produce, and service all kinds of cables, umbilical- or tether systems, used on ROVs/ROTs, cables used for power and control of "permanently"​ installed subsea components like wellhead systems, pumps, manifolds, and transducer arrays. This includes: * Normal dry mate connectors for use subsea * Wet mates for divers or ROV/ROT operation. * Pressure balanced systems for long time use at depths >4000m salt water. We have an extensive stock of connectors and cables and provide hyperbaric test facilities.

Ose Water AS is a Norwegian bottled water and bag-in-box water producer.The water source is Ose which provides high quality natural mineral water. The company aim to be in production for international sale in Q1 2019. Ose Water AS is a producer of natural mineral water from the Ose spring in Bygland municipality, Aust-Agder county in Norway.

We have developed a system for calculating and supplying Solcelle, and wind power for Scandinavia. In addition to this, we have obtained a license as a power supplier, so we can offer our customers both purchases and sales of green power. Why solar cells? Sun provides energy. As an energy source, the sun is unsurpassed. Every year, the earth receives 15,000 times more energy from the sun than the earth's population uses. Even in Norway, the sun provides 1,500 times more energy than what we use. Depending on where on the globe you are, the sun provides an amount of energy from 700 to over 2,200 kWh/m2 per year.

Oncoinvent AS is a privately held Norwegian company established in 2010. The company is committed to developing new innovative products to provide better treatment options to cancer patients. The innovations being developed by Oncoinvent AS are a result of the extensive experience with the development of radionuclide-based cancer treatments of two of the founders, Dr. Roy H. Larsen and Professor of clinical oncology Øyvind S. Bruland. Larsen and Bruland are the inventors of the first FDA and EMA-approved alpha-emitting pharmaceutical product Xofigo® (Bayer AG), as well as of the beta-emitting radio-immunotherapeutic product candidate Betalutin® (Nordic Nanovector ASA). Oncoinvent's lead product candidate, Radspherin®, is a novel alpha-emitting radioactive microsphere designed for the treatment of metastatic cancers in body cavities. Radspherin® has been shown to cause a significant reduction in tumor cell growth. It is anticipated that the product can potentially treat several forms of metastatic cancer. The first clinical indication for Radspherin® will be the treatment of peritoneal carcinomatosis. Clinical development will be conducted in collaboration with European and American clinical research centers.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.